MOH

Molina Healthcare, Inc.

HEALTHCARE • MEDICAL - HEALTHCARE PLANS

Current Price $156.88 Target: $170.00

52-Week Range

$133.40 $359.97

Current price is 10.4% of 52-week range

Key Metrics

Market Cap $8.2B
P/E Ratio 9.2
Current Ratio N/A
EPS $16.24
Dividend Yield 0.0%
Profit Margin 2.06%
Beta 0.5
PEG Ratio N/A
ROE N/A
Operating Earnings Growth Rate -20.45%

Bullbiscuit Analysis

61

Overall Score

Score Breakdown

Good

Momentum Signal

Score Breakdown (what to buy)

Value 100
Growth 50
Financial Strength 40
Social Sentiment 40
AI Prediction 65

Momentum Score (when to buy)

Momentum Score 60

AI Overview

Last updated 12 days ago

Molina Healthcare has demonstrated robust financial performance in recent quarters, capitalizing on the expanding Medicaid and Medicare managed care markets. The company's latest earnings report shows strong revenue growth driven by expanded state contracts and increased enrollment in their government-sponsored healthcare plans. Their consistent operational efficiency and disciplined cost management have translated into solid profit margins, with earnings per share exceeding analyst expectations and reflecting the company's strategic positioning in the healthcare insurance sector.

The competitive landscape presents both opportunities and challenges for Molina. Recent healthcare policy shifts and potential Medicare expansion create favorable growth pathways, while the company continues to differentiate itself by focusing on underserved populations and value-based care models. Their strategic acquisitions and technology investments in digital health platforms have enhanced their service delivery capabilities, positioning them well to capture market share in increasingly complex healthcare ecosystems. However, potential regulatory changes and increasing competition from larger health insurers remain notable risk factors.

For DIY investors, Molina Healthcare represents an attractive investment opportunity with moderate risk and steady growth potential. Current valuation metrics suggest the stock is reasonably priced relative to its growth trajectory, with analysts projecting continued expansion in Medicaid and Medicare managed care segments. The company's consistent financial performance, strong balance sheet, and strategic market positioning provide a compelling investment thesis. Over the next 12 months, investors can anticipate potential share price appreciation in the range of 12-15%, driven by continued operational improvements and favorable market dynamics in the healthcare insurance sector.

RECOMMENDATION: STRONG BUY

Price & Profitability History

Log in